Obata T et al. |
Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. |
2003 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:12829006
|
Nicholson RA et al. |
Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. |
2003 |
Brain Res. |
pmid:12834914
|
Bojesen IN and Hansen HS |
Binding of anandamide to bovine serum albumin. |
2003 |
J. Lipid Res. |
pmid:12837852
|
Patel S et al. |
The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. |
2003 |
Br. J. Pharmacol. |
pmid:12839875
|
González S et al. |
Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. |
2003 |
Addict Biol |
pmid:12850774
|
Sarker KP and Maruyama I |
Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. |
2003 |
Cell. Mol. Life Sci. |
pmid:12861385
|
Sokal DM et al. |
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. |
2003 |
Neuropharmacology |
pmid:12871657
|
Watanabe H et al. |
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. |
2003 |
Nature |
pmid:12879072
|
Kozak KR et al. |
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. |
2003 |
Biochemistry |
pmid:12885237
|
Storr M et al. |
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. |
2004 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:12893627
|
Dogulu FH et al. |
Intra-arterial simultaneous administration of anandamide attenuates endothelin-1 induced vasospasm in rabbit basilar arteries. |
2003 |
Acta Neurochir (Wien) |
pmid:12910401
|
Fasia L et al. |
Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? |
2003 |
Eur. J. Biochem. |
pmid:12919314
|
Maccarrone M and Finazzi-Agró A |
The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. |
2003 |
Cell Death Differ. |
pmid:12934069
|
Cravatt BF and Lichtman AH |
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. |
2003 |
Curr Opin Chem Biol |
pmid:12941421
|
Helyes Z et al. |
Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. |
2003 |
Life Sci. |
pmid:12941436
|
Franklin A et al. |
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. |
2003 |
J. Neurosci. |
pmid:12944505
|
Fowler CJ et al. |
Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. |
2003 |
Biochem. Pharmacol. |
pmid:12948856
|
Liu J et al. |
Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. |
2003 |
J. Biol. Chem. |
pmid:12949078
|
Segall Y et al. |
Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:12951114
|
Hillard CJ and Jarrahian A |
Cellular accumulation of anandamide: consensus and controversy. |
2003 |
Br. J. Pharmacol. |
pmid:12970089
|
Barinaga M |
Pot, heroin unlock new areas for neuroscience. |
1992 |
Science |
pmid:1335165
|
del Carmen GarcÃa M et al. |
Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14504685
|
Fowler CJ et al. |
Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin. |
2003 |
J Enzyme Inhib Med Chem |
pmid:14506913
|
Ross RA |
Anandamide and vanilloid TRPV1 receptors. |
2003 |
Br. J. Pharmacol. |
pmid:14517174
|
Vandevoorde S et al. |
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase. |
2003 |
J. Med. Chem. |
pmid:14521402
|
Mechoulam R and Lichtman AH |
Neuroscience. Stout guards of the central nervous system. |
2003 |
Science |
pmid:14526067
|
Marsicano G et al. |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity. |
2003 |
Science |
pmid:14526074
|
Gurney AM et al. |
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. |
2003 |
Circ. Res. |
pmid:14551239
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Steffens M et al. |
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14566450
|
Han B et al. |
Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. |
2003 |
J. Nat. Prod. |
pmid:14575438
|
Chen N et al. |
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. |
2003 |
Eur. J. Pharmacol. |
pmid:14575792
|
Johnson RP et al. |
System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:14576090
|
Biswas KK et al. |
Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. |
2003 |
Hepatology |
pmid:14578855
|
Egashira N et al. |
Anandamide inhibits the DOI-induced head-twitch response in mice. |
2004 |
Psychopharmacology (Berl.) |
pmid:14586538
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
McAllister SD et al. |
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. |
2003 |
J. Med. Chem. |
pmid:14613317
|
Seagard JL et al. |
Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:14615281
|
Sparling PB et al. |
Exercise activates the endocannabinoid system. |
2003 |
Neuroreport |
pmid:14625449
|
Okamoto Y et al. |
Molecular characterization of a phospholipase D generating anandamide and its congeners. |
2004 |
J. Biol. Chem. |
pmid:14634025
|
Kollarik M and Undem BJ |
Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. |
2004 |
J. Physiol. (Lond.) |
pmid:14634201
|
Farquhar-Smith WP and Rice AS |
A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. |
2003 |
Anesthesiology |
pmid:14639155
|
Jones S and Howl J |
Cannabinoid receptor systems: therapeutic targets for tumour intervention. |
2003 |
Expert Opin. Ther. Targets |
pmid:14640910
|
Zoratti C et al. |
Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. |
2003 |
Br. J. Pharmacol. |
pmid:14645143
|
Wang H et al. |
Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14645706
|
Nilsson O et al. |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. |
2003 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:14659458
|
Arizzi MN et al. |
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. |
2004 |
Life Sci. |
pmid:14672756
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|
Wenger T et al. |
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. |
2003 |
Neuroendocrinology |
pmid:14688442
|
Kasai HF et al. |
Analyses of anandamide and endocannabinoid-like compounds using collision-induced dissociation in fast atom bombardment ionization-mass spectrometry and gas chromatography/chemical ionization-mass spectrometry. |
2003 |
Anal Sci |
pmid:14696920
|